Skip to main content
Supplement ScienceSupplementScience

Alpha-GPC Dosage Guide

Evidence:Moderate
·

This content is for informational purposes only and does not constitute medical advice. Statements about dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary — consult your healthcare provider before starting any supplement. Full disclaimer

General Dosage

300-600mg daily for cognitive support; up to 1200mg for clinical applications

Maximum dose: 1200mg/day (prescription doses in Europe)

Dosage Recommendations

General recommendation: 300-600mg daily for cognitive support; up to 1200mg for clinical applications

Timing: Morning or pre-workout; divide higher doses into 2-3 servings • Take with food for best absorption.

Dosage by Condition

Cognitive enhancement
300-600mg dailyModerate
Athletic performance
600mg 90 minutes pre-workoutModerate
Cognitive decline
1200mg daily in 3 divided dosesModerate

Upper limit: 1200mg/day (prescription doses in Europe)

Timing & Absorption

Morning or pre-workout; divide higher doses into 2-3 servings

Best taken with food for optimal absorption.

References

  1. RCTDe Jesus Moreno M (2003). Cognitive improvement in mild to moderate Alzheimer's dementia after treatment with the cholinergic precursor choline alfoscerate. Clinical Therapeutics. DOI PubMed
  2. RCTZiegenfuss T, Landis J, Hofheins J (2008). Acute supplementation with alpha-glycerylphosphorylcholine augments growth hormone response to, and peak force production during, resistance exercise. Journal of the International Society of Sports Nutrition. DOI
  3. RCTKawamura T, Okubo T, Sato K, et al. (2012). Glycerophosphocholine enhances growth hormone secretion and fat oxidation in young adults. Nutrition. DOI PubMed
  4. RCTYamashita S, Kawada N, Wang W, Susaki K, et al. (2023). Effects of egg yolk choline intake on cognitive functions and plasma choline levels in healthy middle-aged and older Japanese: a randomized double-blinded placebo-controlled parallel-group study.. Lipids in health and disease. DOI PubMed